Cylindrospermopsin

Discovery

In 1979, 138 inhabitants of Palm Island, Queensland, Australia, were admitted to hospital, suffering various symptoms of gastroenteritis. All of these were children; in addition, 10 adults were affected but not hospitalised. Initial symptoms, including abdominal pain and vomiting, resembled those of hepatitis; later symptoms included kidney failure and bloody diarrhoea. Urine analysis revealed high levels of proteins, ketones and sugar in many patients, along with blood and urobilinogen in lesser numbers. The urine analysis, along with faecal microscopy and poison screening, could not provide a statistical link to the symptoms. All patients recovered within 4 to 26 days, and at the time there was no apparent cause for the outbreak. Initial thoughts on the cause included poor water quality and diet; the illness was coined the "Palm Island Mystery Disease".

At the time, it was noticed that this outbreak coincided with a severe algal bloom in the local drinking water supply, and soon after the focus turned to the dam in question. An epidemiological study of this "mystery disease" later confirmed that the Solomon Dam was implicated, as those who became ill had used water from the dam. It became apparent that a recent treatment of the algal bloom with copper sulfate caused lysis of the algal cells, releasing a toxin into the water.{{cite journal A study of the dam revealed that periodic blooms of algae were caused predominantly by three strains of cyanobacteria: two of the genus Anabaena, and Cylindrospermopsis raciborskii, previously unknown in Australian waters. A mouse bioassay of the three demonstrated that although the two Anabaena strains were non-toxic, C. raciborskii was highly toxic. Later isolation of the compound responsible led to the identification of the toxin cylindrospermopsin.{{cite journal

A later report alternatively proposed that the excess copper in the water was the cause of the disease. The excessive dosing was following the use of least-cost contractors to control the algae, who were unqualified in the field.

Chemistry

Structure determination

Isolation of the toxin using cyanobacteria cultured from the original Palm Island strain was achieved by gel filtration of an aqueous extract, followed by reverse-phase HPLC. Structure elucidation was achieved via mass spectrometry (MS) and nuclear magnetic resonance (NMR) experiments, and a structure (later proven slightly incorrect) was proposed (Figure 1).

This almost-correct molecule possesses a tricyclic guanidine group (rings A, B & C), along with a uracil ring (D). The zwitterionic nature of the molecule makes this highly water-soluble, as the presence of charged areas within the molecule creates a dipole effect, suiting the polar solvent. Sensitivity of key signals in the NMR spectrum to small changes in pH suggested that the uracil ring exists in a keto/enol tautomeric relationship, where a hydrogen transfer results in two distinct structures (Figure 2). It was originally proposed that a hydrogen bond between the uracil and guanidine groups in the enol tautomer would make this the dominant form.

Analogues

A second metabolite of C. raciborskii was identified from extracts of the cyanobacteria after the observation of a frequently occurring peak accompanying that of CYN during UV and MS experiments. Analysis by MS and NMR methods concluded that this new compound was missing the oxygen adjacent to the uracil ring, and was named deoxycylindrospermopsin (Figure 3).

In 1999, an epimer of CYN, named 7-epicyclindrospermopsin (epiCYN), was also identified as a minor metabolite from Aphanizomenon ovalisporum. This occurred whilst isolating CYN from cyanobacteria taken from Lake Kinneret in Israel. The proposed structure of this molecule differed from CYN only in the orientation of the hydroxyl group adjacent to the uracil ring (Figure 4).

Total synthesis

Synthetic approaches to CYN started with the piperidine ring (A), and progressed to annulation of rings B and C. The first total synthesis of CYN was reported in 2000 through a 20-step process.{{cite journal

Improvements to synthetic methods led to a revision of the stereochemistry of CYN in 2001. A synthetic process controlling each of the six stereogenic centres of epiCYN established that the original assignments of both CYN and epiCYN were in fact a reversal of the correct structures.{{cite journal

Stability

One of the key factors associated with the toxicity of CYN is its stability. Although the toxin has been found to degrade rapidly in an algal extract when exposed to sunlight, it is resistant to degradation by changes in pH and temperature, and shows no degradation in either the pure solid form or in pure water. As a result, in turbid and unmoving water the toxin can persist for long periods, and although boiling water will kill the cyanobacteria, it may not remove the toxin.{{cite journal

Toxicology

Toxic effects

Hawkins et al.. demonstrated the toxic effects of CYN by mouse bioassay, using an extract of the original Palm Island strain. Acutely poisoned mice displayed anorexia, diarrhoea and gasping respiration. Autopsy results revealed haemorrhages in the lungs, livers, kidneys, small intestines and adrenal glands. Histopathology revealed dose-related necrosis of hepatocytes, lipid accumulation, and fibrin thrombi formation in blood vessels of the liver and lungs, along with varying epithelial cell necrosis in areas of the kidneys.

A more recent mouse bioassay of the effects of cylindrospermopsin revealed an increase in liver weight, with both lethal and non-lethal doses; in addition the livers appeared dark-coloured. Extensive necrosis of hepatocytes was visible in mice administered a lethal dose, and some localised damage was also observed in mice administered a non-lethal dose.

Toxicity

An initial estimate of the toxicity of CYN in 1985 was that an at 24 hours was 64±5 mg of freeze-dried culture/kg of mouse body weight on intraperitoneal injection. predictions made by Ohtani et al. about the 24‑hour toxicity were considerably higher, and it was proposed that another metabolite was present to account for the relatively low 24‑hour toxicity level measured.

Because the most likely human route of uptake of CYN is ingestion, oral toxicity experiments were conducted on mice. The oral LD50 was found to be 4.4-6.9 mg CYN/kg, and in addition to some ulceration of the oesophageal gastric mucosa, symptoms were consistent with that of intraperitoneal dosing. Stomach contents included culture material, which indicated that these LD50 figures might be overestimated.{{cite journal

Another means of exposure to CYN is related to alterations in the gut microbiome by artificial sweetners. A study including Aspartame conducted at Cedars-Sinai in Los Angeles by Ruchi Mathur, MD detected CYN in the duodenum at levels four times above baseline in Aspartame users, along with alterations in bacterial species.

Mechanism of action

Pathological changes associated with CYN poisoning were reported to be in four distinct stages: inhibition of protein synthesis, proliferation of membranes, lipid accumulation within cells, and finally cell death. Examination of mice livers removed at autopsy showed that on intraperitoneal injection of CYN, after 16 hours ribosomes from the rough endoplasmic reticulum (rER) had detached, and at 24 hours, marked proliferation of the membrane systems of the smooth ER and Golgi apparatus had occurred. At 48 hours, small lipid droplets had accumulated in the cell bodies, and at 100 hours, hepatocytes in the hepatic lobules were destroyed beyond function.

The process of protein synthesis inhibition has been shown to be irreversible, however is not conclusively the method of cytotoxicity of the compound. Froscio et al.. proposed that CYN has at least two separate modes of action: the previously reported protein synthesis inhibition, and an as-yet unclear method of causing cell death. It has been shown that cells can survive for long periods (up to 20 hours) with 90% inhibition of protein synthesis, and still maintain viability. Since CYN is cytotoxic within 16–18 hours it has been suggested that other mechanisms are the cause of cell death.

Cytochrome P450 has been implicated in the toxicity of CYN, as blocking the action of P450 reduces the toxicity of CYN. It has been proposed that an activated P450-derived metabolite (or metabolites) of CYN is the main cause of toxicity.

Due to the structure of CYN, which includes sulfate, guanidine and uracil groups, it has been suggested that CYN acts on DNA or RNA. Shaw et al.. reported covalent binding of CYN or its metabolites to DNA in mice, Humpage et al. also supported this, and in addition postulated that CYN (or a metabolite) acts on either the spindle or centromeres during cell division, inducing loss of whole chromosomes.

The uracil group of CYN has been identified as a pharmacophore of the toxin. In two experiments, the vinylic hydrogen atom on the uracil ring was replaced with a chlorine atom to form 5-chlorocylindrospermopsin, and the uracil group was truncated to a carboxylic acid, to form cylindrospermic acid (Figure 6). Both products were assessed as being non-toxic, even at 50 times the LD50 of CYN. In the previous determination of the structure of deoxycylindrospermopsin, a toxicity assessment of the compound was carried out. Mice injected intraperitoneally with four times the 5-day median lethal dose of CYN showed no toxic effects. As this compound was shown to be relatively abundant, it was concluded that this analogue was comparatively non-toxic. Given that both CYN and epiCYN are toxic, the hydroxyl group on the uracil bridge can be considered necessary for toxicity. As yet, the relative toxicities of CYN and epiCYN have not been compared.

Biosynthesis

The cylindrospermopsin biosynthetic gene cluster (BGC) was described from Cylindrospermopsis raciborskii AWT205 in 2008.

Related toxic blooms and their impact

Since the Palm Island outbreak, several other species of cyanobacteria have been identified as producing CYN: Anabaena bergii, *Anabaena lapponica *, Aphanizomenon ovalisporum,{{cite journal

In August 1997, three cows and ten calves died from cylindrospermopsin poisoning on a farm in northwest Queensland. A nearby dam containing an algal bloom was tested, and C. raciborskii was identified. Analysis by HPLC/mass spectrometry revealed the presence of CYN in a sample of the biomass. An autopsy of one of the calves reported a swollen liver and gall bladder, along with haemorrhages of the heart and small intestine. Histological examination of the hepatic tissue was consistent with that reported in CYN-affected mice.{{cite journal

The effect of a bloom of C. raciborskii on an aquaculture pond in Townsville, Australia was assessed in 1997. The pond contained Redclaw crayfish, along with a population of Lake Eacham Rainbowfish to control the excess food. Analysis revealed that the water contained both extracellular and intracellular CYN, and that the crayfish had accumulated this primarily in the liver but also in the muscle tissue. Examination of the gut contents revealed cyanobacterial cells, indicating that the crayfish had ingested intracellular toxin. An experiment using an extract of the bloom showed that it was also possible to uptake extracellular toxin directly into the tissues. Such bioaccumulation, particularly in the aquaculture industry, was of concern, especially when humans were the end users of the product.

The impact of cyanobacterial blooms has been assessed in economic terms. In December 1991, the world's largest algal bloom occurred in Australia, where 1000 km of the Darling-Barwon River was affected.{{cite journal

Current methods of analysis in water samples

Current methods include liquid chromatography coupled to mass spectrometry (LC-MS),{{cite journal

References

References

1. (September 2003). "Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (Cyanobacteria) isolates". Toxicon.
2. (2001). "Preliminary evidence for in vivo tumour initiation by oral administration of extracts of the blue-green alga cylindrospermopsis raciborskii containing the toxin cylindrospermopsin". Environmental Toxicology.
3. (2012). "Cylindrospermopsin: Water-linked potential threat to human health in Europe". Environmental Toxicology and Pharmacology.
4. Byth S. (July 1980). "Palm Island mystery disease". The Medical Journal of Australia.
5. (April 2003). "The Palm Island mystery disease 20 years on: a review of research on the cyanotoxin cylindrospermopsin". Environmental Toxicology.
6. (November 1985). "Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir". Applied and Environmental Microbiology.
7. Prociv P. (September 2004). "Algal toxins or copper poisoning--revisiting the Palm Island "epidemic"". The Medical Journal of Australia.
8. (October 2001). "Extraction and purification of the zwitterions cylindrospermopsin and deoxycylindrospermopsin from Cylindrospermopsis raciborskii". Environmental Toxicology.
9. (March 2000). "7-Epicylindrospermopsin, a toxic minor metabolite of the cyanobacterium Aphanizomenon ovalisporum from lake Kinneret, Israel". Journal of Natural Products.
10. Heintzelman, G.R.. (1996). "Imino Diels-Alder-Based Construction of a Piperidine A-Ring Unit for Total Synthesis of the Marine Hepatotoxin Cylindrospermopsin". The Journal of Organic Chemistry.
11. (March 1997). "Isolation and toxicity of Cylindrospermopsis raciborskii from an ornamental lake". Toxicon.
12. (July 1994). "Electron microscopic studies on experimental poisoning in mice induced by cylindrospermopsin isolated from blue-green alga Umezakia natans". Toxicon.
13. (August 2003). "Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes". Environmental Toxicology.
14. (May 1994). "The role of glutathione in the toxicity of a novel cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes". Biochemical and Biophysical Research Communications.
15. (January 1995). "Inhibition of reduced glutathione synthesis by cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes". [[Biochemical Pharmacology (journal).
16. (February 2000). "Cylindrospermopsin, a cyanobacterial alkaloid: evaluation of its toxicologic activity". Therapeutic Drug Monitoring.
17. (October 2002). "Genotoxicity investigation of a cyanobacterial toxin, cylindrospermopsin". Toxicon.
18. (December 2000). "Micronucleus induction and chromosome loss in transformed human white cells indicate clastogenic and aneugenic action of the cyanobacterial toxin, cylindrospermopsin". Mutation Research.
19. (February 2001). "Uracil moiety is required for toxicity of the cyanobacterial hepatotoxin cylindrospermopsin". Journal of Toxicology and Environmental Health, Part A.
20. (2007-12-07). "Characterization of the Gene Cluster Responsible for Cylindrospermopsin Biosynthesis". American Society for Microbiology.
21. (December 2006). "First observation of cylindrospermopsin in Anabaena lapponica isolated from the boreal environment (Finland)". Environmental Toxicology.
22. (January 1994). "Isolation of cylindrospermopsin from a cyanobacterium Umezakia natans and its screening method". Toxicon.
23. (2007). "First Report of the Cyanotoxin Anatoxin-A from Aphanizomenon issatschenkoi (cyanobacteria)". Journal of Phycology.
24. (August 2001). "First report of the cyanobacterial toxin cylindrospermopsin in New Zealand". Toxicon.
25. (1999). "The accumulation of cylindrospermopsin from the cyanobacterium Cylindrospermopsis raciborskii in tissues of the Redclaw crayfish Cherax quadricarinatus". Toxicon.
26. (November 2002). "HPLC-PDA detection of cylindrospermopsin--opportunities and limits". Water Research.
27. (November 2023). "Consuming artificial sweeteners may alter the structure and function of duodenal microbial communities". iScience.